The efficacy and safety of intravenous bisphosphonates in the treatment of primary hyperparathyroidism complicated by hyperculcemia crisis

Guiyan HAN; Ou WANG; Xiaoping XING; Xunwu MENG; Xiaolan LIAN; Heng GUAN; Wei YE; Weibo XIA; Mei LI; Yan JIANG; Yingying HU; Huaicheng LIU; Quancai CUI

The efficacy and safety of intravenous bisphosphonates in the treatment of primary hyperparathyroidism complicated by hyperculcemia crisis / 中华内科杂志

Guiyan HAN; Ou WANG; Xiaoping XING; Xunwu MENG; Xiaolan LIAN; Heng GUAN; Wei YE; Weibo XIA; Mei LI; Yan JIANG; Yingying HU; Huaicheng LIU; Quancai CUI.

Chinese Journal of Internal Medicine ; (12): 729-733, 2009.

Article in Zh | WPRIM | ID: wpr-393083

Responsible library: WPRO

ABSTRACT

ABSTRACT

creatinine concentration. Conclusion Bisphosphonates can decrease serum total calcium levels in hypercalcemia crisis caused by PHPT effectivelywith mild adverse events.

Key words

Hyperparathyroidism; Hypercalcemia crisis; Bisphosphonate

Fulltext

Add to My VHL

XML

Search on Google

Full text: 1 Index: WPRIM Language: Zh Journal: Chinese Journal of Internal Medicine Year: 2009 Type: Article

Fulltext

Add to My VHL

XML

Search on Google

Full text: 1 Index: WPRIM Language: Zh Journal: Chinese Journal of Internal Medicine Year: 2009 Type: Article